View in EDS HTML Full Text PDF Full Text

A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.

Saved in:
Bibliographic Details
Title: A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
Authors: Jenks JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Amin S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Sponholtz MR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Kumar A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Venkatayogi S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Tu JJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Karthigeyan K; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America., Valencia SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Connors M; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America., Harnois MJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Rochat E; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America., Permar SR; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2023 Jan 20; Vol. 19 (1), pp. e1011107. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36662906
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jenks+JA%22">Jenks JA</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Amin+S%22">Amin S</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Sponholtz+MR%22">Sponholtz MR</searchLink>; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Kumar+A%22">Kumar A</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Wrapp+D%22">Wrapp D</searchLink>; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Venkatayogi+S%22">Venkatayogi S</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Tu+JJ%22">Tu JJ</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Karthigeyan+K%22">Karthigeyan K</searchLink>; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Valencia+SM%22">Valencia SM</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Connors+M%22">Connors M</searchLink>; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Harnois+MJ%22">Harnois MJ</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Hora+B%22">Hora B</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Rochat+E%22">Rochat E</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22McLellan+JS%22">McLellan JS</searchLink>; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Wiehe+K%22">Wiehe K</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Permar+SR%22">Permar SR</searchLink>; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2023 Jan 20; Vol. 19 (1), pp. e1011107. <i>Date of Electronic Publication: </i>2023 Jan 20 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36662906
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1011107
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1011107
    Titles:
      – TitleFull: A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jenks JA
      – PersonEntity:
          Name:
            NameFull: Amin S
      – PersonEntity:
          Name:
            NameFull: Sponholtz MR
      – PersonEntity:
          Name:
            NameFull: Kumar A
      – PersonEntity:
          Name:
            NameFull: Wrapp D
      – PersonEntity:
          Name:
            NameFull: Venkatayogi S
      – PersonEntity:
          Name:
            NameFull: Tu JJ
      – PersonEntity:
          Name:
            NameFull: Karthigeyan K
      – PersonEntity:
          Name:
            NameFull: Valencia SM
      – PersonEntity:
          Name:
            NameFull: Connors M
      – PersonEntity:
          Name:
            NameFull: Harnois MJ
      – PersonEntity:
          Name:
            NameFull: Hora B
      – PersonEntity:
          Name:
            NameFull: Rochat E
      – PersonEntity:
          Name:
            NameFull: McLellan JS
      – PersonEntity:
          Name:
            NameFull: Wiehe K
      – PersonEntity:
          Name:
            NameFull: Permar SR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 01
              Text: 2023 Jan 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1